Skip to main content
OpenTrials
Completed

NCT Number: NCT00934609

Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure

The study investigates the safety and effectiveness of a 12 week endurance training program for patients with chronic heart failure

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute of Sports- and Preventive Medicine, Saarland University

Saarbrücken, Saarland, 66123, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • chronic heart failure NYHA stage 2 and 3

Exclusion criteria

  • Valvular disease
  • recent decompensation
  • Other complaints that might interfere with ergometer exercise

Treatment and study plan

Endurance training

Behavioral

45 min ergometer cycling at the ventilatory anaerobic threshold 4 times per week for 12 weeks

Primary outcomes

  1. Physical capacity

Secondary outcomes

  1. Left ventricular function

  2. occurence of complications

    Time frame: within study period

Sponsors and collaborators

Lead sponsor

Universität des Saarlandes

Other

Collaborators

  • The German Heart Foundation

Registry information

Official study title

Effects of 12-weeks Endurance Training in Patients With Chronic Heart Failure Due to Dilated Cardiomyopathy

Acronym: CHF

Important dates

First posted
Jul 8, 2009
Registry last updated
Sep 18, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.